Oryza Pharma

Oryza Pharmaceuticals is a specialty pharmaceutical company based in Coralville, Iowa, that specializes in the development and commercialization of complex generic and branded drug products. The company focuses on high-entry-barrier products, particularly in topical formulations such as creams, gels, and ointments, as well as oral solids. Oryza utilizes the ANDA and 505(b)(2) regulatory pathways to bring cost-effective and improved therapeutic options to the market. Their expertise encompasses formulation development, analytical testing, and regulatory strategy, with a primary focus on dermatology and pain management. The company operates a state-of-the-art facility that supports both R&D and manufacturing activities.